On the afternoon of September 12, 2025, Chen Guojun, Party Leadership Member and Secretary-General of the Ningbo Municipal People's Congress Standing Committee, visited Zhejiang Tianyuan Biotechnology Co., Ltd. (Ninghai Base) for an inspection and research tour. Company Chairman Huang Bisheng and General Manager Jiao Mingming, along with their team, warmly received the delegation.

      Accompanied by Chairman Huang Bisheng and other company representatives, Chen Guojun toured the company's technology corridor and laboratories. During the subsequent symposium, Chairman Huang mentioned that Zhejiang Tianyuan Biotechnology Co., Ltd., as an industry pioneer, always adheres to technological innovation as its core driving force, actively builds high-level scientific research and innovation platforms, and has established extensive cooperative relationships with research institutions such as the National Health Commission's Research Institute, the National Stem Cell Transformation Resource Bank, and Ningbo University, continuously promoting technological innovation and breakthroughs. General Manager Jiao Mingming added that the company also focuses on talent introduction and cultivation, gathering a group of experts represented by Dr. Chen Junjie and Dr. Liu Guangcheng, who possess extensive experience and outstanding skills in the field of cell research, providing solid talent support for the company's sustainable development.

      After listening to the company's detailed introduction, Chen Guojun highly affirmed the efforts and achievements made by Zhejiang Tianyuan Biotechnology Co., Ltd. in scientific research innovation and talent introduction. He particularly praised the research results of Dr. Chen Junjie, Technical Director, in the field of iPS-induced pluripotent stem cell technology, and the suspension co-culture cell technology of Dr. Liu Guangcheng, Director of the Cell Laboratory, stating that these are important manifestations of the company's scientific research strength. Chen Guojun pointed out that Tianyuan Bio's exploration and practice in the biomedical field are at the forefront of the industry, having not only made significant progress in technology research and development but also set an example in talent team construction. The company's scientific research innovation achievements and advanced technology services provide strong support for promoting the high-quality development of the local economy and the upgrading of the life and health industry.

      Chen Guojun also stated that the Municipal People's Congress will continue to pay attention to and support the innovative development of Tianyuan Bio, providing a better policy environment and service guarantees for the enterprise. He expressed hope that the company will continue to increase investment in scientific research, strengthen talent introduction and cultivation, and make new breakthroughs in the field of biomedicine, contributing more to the development of China's life and health industry.

      Finally, Chairman Huang Bisheng expressed his gratitude for Secretary-General Chen Guojun's visit and stated that the company would take this investigation and guidance as an opportunity to further enhance its independent innovation capability, accelerate the transformation of scientific and technological achievements, expand business areas, and strive to become a leading domestic biomedicine innovation enterprise, contributing more to the promotion of local economic development and the progress of human health.

      The investigation was accompanied by Zhou Haijie, Deputy Director-General of the Ningbo Municipal People's Congress Standing Committee General Office; Ye Yijin, Deputy Director of the Ninghai County People's Congress Standing Committee; and Yan Yijing, Director of the Deputy Affairs Committee of the Ninghai County People's Congress Standing Committee, among others.

Zhejiang Tianyuan Biotechnology Co., Ltd., founded in 2017, is a national high-tech enterprise dedicated to cell research, development, production, operation, and service. It possesses valuable resource banks including an HLA Umbilical Cord Matching Library, iPS Seed Cell Bank, and Cancer Cell Bank. The company is the drafting unit for the National Health Commission's association standard on immune function assessment methods. In collaboration with the National Health Commission's Research Institute, it has co-established a Joint Laboratory for Metabolic Immunity Monitoring. Furthermore, it serves as important research and service platforms, including the Ningbo Storage Center of the National Stem Cell Transformation Resource Bank and the Achievement Transformation Center of the National Health Commission's Research Institute.